Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06172322
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2023-11-24
Brief Title:
A Phase Ibâ…¡ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive HER-2 Negative Breast Cancer
Sponsor:
Nanjing Chia-tai Tianqing Pharmaceutical
Organization:
Nanjing Chia-tai Tianqing Pharmaceutical
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-24
First Submit QC Date:
December 6 2023
Study First Post Date:
2023-12-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-22
Last Update Post Date:
2024-04-23
Last Update Post Date Type:
ACTUAL